mp.weixin.qq.com· 良医汇肿瘤资讯·· 3 hours agoPickScore72
2026 WCLC ES06 Session: Lung Cancer Biomarkers Move From Immunohistochemistry to Omics and AI
2026 WCLC 专场合集｜ES06：肺癌生物标志物从免疫组化走向组学与AI
In brief
The 2026 WCLC ES06 session brought together four presentations reviewing research progress on lung cancer biomarkers from four angles: omics-based classification, spatial omics and AI, ADC target protein expression, and cytology-based triage.
Why it matters
The session's four WCLC talks trace lung cancer biomarkers from immunohistochemistry toward omics and AI, with interpretable methods such as mIHC-LAND offering transferable ways to mine spatial information from routine slides.
Source: mp.weixin.qq.com · mp.weixin.qq.com